Page 4 - Keith Flaherty News Today

Silicon Valley entrepreneur Vivek Wadhwa wants to create a portable device that can detect cancer just by breathing into it – here is what you need to know about it and whether it would work.

Wadhwa’s career as a public commentator won both him fame and notoriety. In a series of opinion columns in the Washington Post in the 2010s he had a habit of taking positions that rankled the Silicon Valley establishment.

Over the last five years Vivek Wadhwa, an entrepreneur and academic who's well known in Silicon Valley, has been working on a longshot project to detect cancer in people using only their breath - similar to using a breathalyzer.

Entrepreneur Vivek Wadhwa dedicated past 5 years to a developing a method to detect cancer in individuals through their breath, similar to using a breathalyzer.

Thirteen people in the rubber industry have completed a one-week training course in seal product design and manufacturing, organized by the Association for Rubber Products Manufacturers.

Multiple successor trials are in the works based on hits, misses and overall knowledge gained from one of the first precision medicine platform trials.

Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level Hospital chiefs and trustees defend this as boosting public-private partnerships, but critics say these board positions - some paying millions of dollars - raise troubling issues of conflict of interest and hospital priorities. By Liz Kowalczyk, Spotlight fellow Sarah L. Ryley, Mark Arsenault and Spotlight editor Patricia Wen Globe Staff and Globe Staff,Updated April 3, 2021, 4:54 p.m. Email to a...

 E-Mail A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds. Led by NYU Grossman School of Medicine and Perlmutter Cancer Center researchers, the investigation looked at adults with undetectable levels of freely circulating tumor DNA (ctDNA) four weeks into drug treatment for metastatic melanoma tumors that ca...

With biotech funding at ‘all-time high,’ Scorpion scoops up $162 million By Anissa Gardizy Globe Staff,Updated January 7, 2021, 7:00 a.m. Email to a Friend Just over two months after announcing its debut with $108 million in funding, Boston startup Scorpion Therapeutics said Thursday it has raised an even larger amount of venture capital. Scorpion, which focuses on “precision medicine” for cancer, said it has completed a $162 million funding round, bringing the biotech’...

Wicked Local A two-alarm fire broke out in a three-story apartment building in Packards Corner on the Allston line Monday evening, Dec. 28, displacing about 30 Brookline residents and filling the sky with black smoke. The Brookline and Boston fire departments responded to the multi-unit apartment building at 16 Hamilton Road shortly after 4 p.m., according to Brookline Fire Department Chief of Operations Keith Flaherty. There, the firefighters found heavy fire conditions on the buildings thir...